{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:21:19Z","timestamp":1761942079980,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jbo.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T12:51:39Z","timestamp":1517835099000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study"],"prefix":"10.1016","volume":"10","author":[{"given":"Roger","family":"von Moos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves Pascal","family":"Acklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindrich","family":"Finek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Maniadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Hechmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harm","family":"Sleeboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jbo.2018.01.003_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11912-015-0495-4","article-title":"Radionuclide therapies in prostate cancer: integrating Radium-223 in the treatment of patients with metastatic castration-resistant prostate cancer","volume":"18","author":"Nilsson","year":"2016","journal-title":"Curr. Oncol. Rep."},{"issue":"12","key":"10.1016\/j.jbo.2018.01.003_bib3","first-page":"3497","article-title":"Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid","volume":"21","author":"von Moos","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jbo.2018.01.003_bib4","unstructured":"WHO, WHO\u2019s Cancer Pain Ladder for Adults. \u3008http:\/\/www.who.int\/cancer\/palliative\/painladder\/en\u3009. (accessed 26 January 2017)."},{"issue":"Suppl. 7","key":"10.1016\/j.jbo.2018.01.003_bib5","article-title":"Management of cancer pain: ESMO Clinical Practice Guidelines","volume":"23","author":"Ripamonti","year":"2012","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2018.01.003_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2010.11.026","article-title":"Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline","volume":"79","author":"Lutz","year":"2011","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"5","key":"10.1016\/j.jbo.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","article-title":"The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group","volume":"50","author":"Tong","year":"1982","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jbo.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.1994.12.11.2345","article-title":"Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease","volume":"12","author":"Townsend","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jbo.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S1470-2045(12)70473-4","volume":"13","author":"Logothetis","year":"2012","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2018.01.003_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urolonc.2005.06.020","article-title":"Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis","volume":"24","author":"Saad","year":"2006","journal-title":"Urol. Oncol.: Semin. Orig. Investig."},{"issue":"5","key":"10.1016\/j.jbo.2018.01.003_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3111\/13696998.2013.779921","article-title":"Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study","volume":"16","author":"Hechmati","year":"2013","journal-title":"J. Med. Econ."},{"issue":"4","key":"10.1016\/j.jbo.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jval.2010.11.014","article-title":"Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System","volume":"14","author":"Felix","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jbo.2018.01.003_bib13","first-page":"755","article-title":"The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain","volume":"19","author":"Pockett","year":"2010","journal-title":"Eur. J. Cancer Care"},{"issue":"16","key":"10.1016\/j.jbo.2018.01.003_bib14","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.003_bib15","first-page":"373","article-title":"Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy","volume":"15","author":"Bradley","year":"2007","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jbo.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0167-8140(00)00214-0","article-title":"Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system?","volume":"56","author":"Lievens","year":"2000","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.jbo.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmonc.2012.02.015","article-title":"Health-resource utilization attributable to skeletal-related events in patients with advanced cancers associated with bone metastases: results of the US cohort from a multicenter observational study","volume":"9","author":"Mahmood","year":"2012","journal-title":"Community Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2004.12.007","article-title":"Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project","volume":"75","author":"Bentzen","year":"2005","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healthpol.2006.05.006","article-title":"Accessibility as a major determinant of radiotherapy underutilization: a population based study","volume":"80","author":"Pagano","year":"2007","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.003_bib20","first-page":"381","article-title":"Managing the adverse effects of radiation therapy","volume":"82","author":"Berkey","year":"2010","journal-title":"Am. Fam. Physician"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.003_bib21","first-page":"451","article-title":"Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial","volume":"15","author":"Loblaw","year":"2007","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.003_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/annonc\/mdi122","article-title":"The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer","volume":"16","author":"Weinfurt","year":"2005","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clon.2011.08.008","article-title":"Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases","volume":"24","author":"Caissie","year":"2012","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"5","key":"10.1016\/j.jbo.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.urology.2010.05.026","article-title":"Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer","volume":"76","author":"Saad","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.jbo.2018.01.003_bib25","unstructured":"European Medicines Agency, Xtandi (enzalutamide) Summary of Product Characteristics. \u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002639\/WC500144996.pdf\u3009. (accessed 26 January 2017)."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137417301045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137417301045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:16:30Z","timestamp":1761941790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137417301045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"alternative-id":["S2212137417301045"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2018.01.003","relation":{},"ISSN":["2212-1374"],"issn-type":[{"type":"print","value":"2212-1374"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}